CD40 ligand triggered interleukin-6 secretion in multiple myeloma

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Interleukin-6 (IL-6) is implicated in multiple myeloma (MM) growth via autocrine or paracrine mechanisms.
• The specific molecules triggering IL-6 secretion in MM and bone marrow cells are not fully understood.

Purpose of the Study:

• To investigate the expression and functional role of CD40 in MM, plasma cell leukemia (PCL), and bone marrow stromal cells (BMSCs).
• To determine if CD40 signaling influences IL-6 secretion and MM cell proliferation.

Main Methods:

• Assessed CD40 expression on MM cells, PCL cells, and BMSCs using flow cytometry.
• Stimulated cells with CD40 ligand (CD40LT) and measured IL-6 secretion and cell surface marker expression.
• Utilized anti-CD40 monoclonal antibody (MoAb) to block CD40-mediated effects and employed cell sorting to isolate myeloma and non-myeloma cells.

Main Results:

• CD40 was highly expressed on MM cells (>90%) and BMSCs (>70%).
• CD40LT stimulation significantly increased IL-6 secretion from MM cells, BMSCs, and their respective cell lines, an effect blocked by anti-CD40 MoAb.
• MM-derived BMMCs and BMSCs secreted more IL-6 than those from healthy donors, with further increases upon CD40L stimulation. CD40LT also enhanced MM cell proliferation and IL-6 secretion.

Conclusions:

• CD40L plays a crucial role in triggering IL-6 secretion by both MM cells and BMSCs.
• These findings support the potential for IL-6-mediated autocrine and paracrine growth mechanisms in MM, driven by CD40 signaling.